- metabolic activity of CYP1A2 was significantly increased in T2D patients compared to control (p = 0.010), - but when the 19 diabetic patients who are under insulin injection were removed, the difference was no longer significant (p = 0.121). The gene discussed is CYP1A2; the disease is type 2 diabetes mellitus.